Related Experiment Videos
Hemophilia: a practical approach to genetic testing.
1Department of Internal Medicine, Division of Hematology, Special Coagulation DNA Diagnostic Laboratory, and Comprehensive Hemophilia Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. pruthi.rajiv@mayo.edu
Mayo Clinic Proceedings
|November 22, 2005
Summary
Genetic testing is crucial for diagnosing and counseling patients with hemophilia A and B. Advances in factor concentrates and comprehensive care have improved quality of life and longevity for those with bleeding disorders.
Area of Science:
- Hematology
- Medical Genetics
Background:
- Congenital bleeding disorders, primarily hemophilia and von Willebrand disease, significantly impact patient health.
- Modern management strategies, including advanced clotting factor concentrates and specialized care centers, have enhanced patient outcomes.
- Genetic advancements have enabled the development of sophisticated diagnostic tools.
Purpose of the Study:
- To present a practical framework for utilizing genetic testing in the management of hemophilia A and B.
- To highlight the importance of genetic testing for informed genetic counseling.
Main Methods:
- Review of current genetic testing methodologies for hemophilia A and B.
- Discussion of the role of genetic testing in patient and family counseling.
- Integration of genetic testing into comprehensive care models.
Main Results:
- Genetic testing provides critical information for diagnosing hemophilia A and B.
- Availability of genetic tests has increased, aiding in genetic counseling.
- Recombinant clotting factor concentrate development is linked to genetic discoveries.
Conclusions:
- Genetic testing is an essential component of modern hemophilia A and B management.
- Appropriate genetic counseling, supported by testing, is vital for affected families.
- Continued advancements in genetic technologies promise further improvements in care.